US2019099505A1PendingUtilityA1
Coated up-conversion nanoparticles
Assignee: UNIV MASSACHUSETTS MEDICAL SCHOOLPriority: May 30, 2012Filed: Dec 6, 2018Published: Apr 4, 2019
Est. expiryMay 30, 2032(~5.8 yrs left)· nominal 20-yr term from priority
C01F 17/36C01P 2002/84C09K 11/7773C01P 2004/02A61K 49/0052C01P 2004/64A61K 49/0067C09K 11/025A61K 49/0065A61K 49/0019A61K 49/0093C01P 2002/72C01P 2004/04B82Y 5/00A61K 41/008C01F 17/0031
71
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides novel biocompatible upconversion nanoparticle (UCNP) that comprises a core of cubic nanocrystals (e.g., comprising α-Na Lna, Lnb Lnc F4) and an epitaxial shell (e.g., formed from CaF2; wherein Lnb is Yb), and related methods of preparation and uses thereof.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 - 62 . (canceled)
63 . A method of whole-body imaging of an animal, comprising:
administering to the animal a biocompatible upconversion nanoparticle comprising:
a core of cubic nanocrystals comprising α-Na (Y, Yb, Tm)F 4 ; and
an epitaxial shell formed from CaF 2 ,
wherein the molar ratio of Tm/(Y+Yb+Tm) is a about 0.5±0.02%, and the molar ratio of Yb/(Y+Yb+Tm) is greater than 30%; exciting the nanoparticle with a laser a wavelength in the range of about 900 nm to about 1064 nm; and recording the emission luminescence at a wavelength in the range of about 980 nm to about 800 nm.
64 . The method of claim 63 , wherein the excitation wavelength is about 980 nm.
65 . The method of claim 63 , wherein the emission luminescence is about 800 nm.
66 . A method for activating a light sensitive molecule, comprising:
administering to a cell an upconversion nanoparticle coated with a light sensitive molecule; exciting the nanoparticle with a laser having a wavelength from about 900 nm to about 1064 nm; causing the particle to emit a luminescence at a wavelength of from about 340 nm to about 380 nm; and activating the light sensitive molecule.
67 . The method of claim 66 , wherein the nanoparticle comprises a core of cubic nanocrystals comprising α-Na (Y, Yb, Tm)F 4 ; an epitaxial shell formed from CaF 2 ; and an outer layer of an organic acid which covers the epitaxial shell, wherein the molar ratio of Tm/(Y+Yb+Tm) is a about 0.5±0.02%; and, the molar ratio of Yb/(Y+Yb+Tm) is greater than 30%.
68 . The method of claim 66 , wherein the excitation wavelength is about 980 nm, and the emission luminescence of the nanoparticle is about 365 nm.
69 . The method of claim 66 , wherein the light sensitive molecule is activated at a wavelength from about 340 nm to about 380 nm.
70 . The method of claim 66 , wherein the light sensitive molecule are derivatives of the 2-nitrobenzyl groups and the coumarin moieties and their protected biological active macromolecules.Join the waitlist — get patent alerts
Track US2019099505A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.